Improved Performance
with Pharmacy
Optimization

How much do you know about your Portfolio Company’s pharmacy health and well-being?

When it comes to creating Portfolio Company (PortCo) value through operational efficiencies, pharmacy benefits are frequently overlooked yet offer opportunities for significant EBITDA improvement.  

Healthcare is typically the second largest line item on a PortCo’s P&L, just below payroll. Pharmacy is the top driver of that spend and is seeing a sharp increase year over year due to the rising cost and use of specialty medications. As the #1 benefit used by PortCo employees, proper management of pharmacy benefits offers significant opportunity to reduce costs and mitigate risk.

Improve Your Portfolio Company Pharmacy Expense with Guaranteed Savings, Lower Risk, and Transparent Results

RxBenefits partners with over 350 PortCos representing over 100 PE firms to design solutions that optimize contracts, uncover unnecessary spending, and deliver predictability long-term.

We offer pharmacy pricing like a Fortune 10 company; based on aggregate 3M members and $3B in annual pharmacy spend our clients see 28% first year contract savings on average. Then we layer our clinical programs that manage cost and minimize trend growth by removing unnecessary drug spend and mitigating the risk of future high-cost claims for an additional 5-7% savings.

Independent PharmD-led utilization management and advanced oversight of costly specialty medications to boost EBITDA through cost savings and risk stratification

Supplemental stop-loss solution to mitigate current and future risk of catastrophic, and often recurring, specialty claims

Award-winning service that delivers high client and member satisfaction with limited disruption

Private Equity analytics platform providing individual company and aggregate reporting with near real-time spend analysis and predictive modeling

This field is for validation purposes and should be left unchanged.